Which US companies depend most on US federal money?
Among 290 US-listed companies with computable shares, LOCKHEED MARTIN CORPORATION shows the highest government dependency of the companies with at least $1B in revenue: In fiscal year 2025, US federal obligations equal 83.6% of LOCKHEED MARTIN CORPORATION's reported revenue - $62.7B in federal awards against $75.0B in revenue as filed with the SEC.
Cite as: FACTANKER, https://factanker.com/government-dependency
Each company links to its own page with the full time series and the evidence tree: revenue facts (SEC filings), award records (USAspending) and identity links.
Companies with at least $1B in revenue
| Company | Share | Federal obligations | Revenue | Latest FY |
|---|---|---|---|---|
| LOCKHEED MARTIN CORPORATION | 83.6% | $62.7B | $75.0B | FY 2025 |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | 37.5% | $2.7B | $7.3B | FY 2026 |
| CORECIVIC, INC. | 26.8% | $591.7M | $2.2B | FY 2025 |
| AEROVIRONMENT, INC | 25.5% | $504.8M | $2.0B | FY 2026 |
| THE BOEING COMPANY | 24.8% | $22.2B | $89.5B | FY 2025 |
| L3HARRIS TECHNOLOGIES, INC. | 9.6% | $2.1B | $21.3B | FY 2025 |
| RTX CORPORATION | 8.2% | $7.3B | $88.6B | FY 2025 |
| TETRA TECH INC | 8.1% | $440.1M | $5.4B | FY 2025 |
| PALANTIR TECHNOLOGIES INC. | 6.2% | $276.0M | $4.5B | FY 2025 |
| QUIDEL CORP | 6.0% | $102.4M | $1.7B | FY 2021 |
| OCEANEERING INTERNATIONAL INC | 4.7% | $123.9M | $2.6B | FY 2025 |
| HONEYWELL INTERNATIONAL INC. | 4.0% | $1.5B | $37.4B | FY 2025 |
| MCKESSON CORPORATION | 2.7% | $11.1B | $403.4B | FY 2026 |
| Manhattan Associates, Inc. | 2.6% | $28.2M | $1.1B | FY 2025 |
| W.W. GRAINGER, INC. | 2.0% | $358.5M | $17.9B | FY 2025 |
| MOTOROLA SOLUTIONS INC | 1.7% | $193.7M | $11.7B | FY 2025 |
| TERADYNE, INC | 1.6% | $51.1M | $3.2B | FY 2025 |
| SENECA FOODS CORP | 1.2% | $18.6M | $1.6B | FY 2025 |
| Gartner, Inc. | 0.9% | $61.2M | $6.5B | FY 2025 |
| AIR PRODUCTS AND CHEMICALS, INC. | 0.9% | $106.7M | $12.0B | FY 2025 |
| ABIOMED, INC. | 0.9% | $9.2M | $1.0B | FY 2022 |
| ILLUMINA, INC. | 0.8% | $33.9M | $4.3B | FY 2025 |
| STEELCASE INC. | 0.7% | $23.3M | $3.2B | FY 2025 |
| NUVASIVE, INC. | 0.7% | $7.8M | $1.2B | FY 2022 |
| AGILENT TECHNOLOGIES, INC. | 0.6% | $42.8M | $6.9B | FY 2025 |
| CATERPILLAR INC | 0.6% | $420.7M | $67.6B | FY 2025 |
| CUMMINS INC | 0.6% | $191.9M | $33.7B | FY 2025 |
| TUTOR PERINI CORPORATION | 0.5% | $29.8M | $5.5B | FY 2025 |
| Frontier Communications Parent, Inc. | 0.5% | $31.0M | $5.9B | FY 2024 |
| TYSON FOODS, INC. | 0.4% | $227.3M | $54.4B | FY 2025 |
| PARKER-HANNIFIN CORPORATION | 0.4% | $81.6M | $21.5B | FY 2026 |
| ANDERSONS INC | 0.3% | $36.4M | $11.0B | FY 2025 |
| CACI International Inc | 0.3% | $30.2M | $9.6B | FY 2026 |
| COLUMBUS MCKINNON CORP | 0.3% | $3.7M | $1.2B | FY 2026 |
| KEYSIGHT TECHNOLOGIES INC | 0.3% | $15.4M | $5.4B | FY 2025 |
| Ford Motor Co | 0.2% | $474.0M | $187.3B | FY 2025 |
| FTI CONSULTING, INC. | 0.2% | $8.8M | $3.8B | FY 2025 |
| EQUINIX, INC. | 0.2% | $21.2M | $9.2B | FY 2025 |
| INTUITIVE SURGICAL, INC. | 0.2% | $21.9M | $10.1B | FY 2025 |
| PPG INDUSTRIES INC | 0.2% | $31.2M | $15.9B | FY 2025 |
| HEWLETT PACKARD ENTERPRISE COMPANY | 0.2% | $66.3M | $34.3B | FY 2025 |
| HOLOGIC INC | 0.2% | $7.0M | $4.1B | FY 2025 |
| BIO-RAD LABORATORIES, INC. | 0.1% | $4.0M | $2.6B | FY 2025 |
| ROCKWELL AUTOMATION, INC. | 0.1% | $11.9M | $8.3B | FY 2025 |
| STERICYCLE INC | 0.1% | $3.4M | $2.7B | FY 2023 |
| MICROSOFT CORPORATION | 0.1% | $369.1M | $331.8B | FY 2026 |
| COMMUNITY HEALTH SYSTEMS, INC. | 0.1% | $12.2M | $12.5B | FY 2025 |
| ENERGIZER HOLDINGS, INC. | 0.1% | $2.8M | $3.0B | FY 2025 |
| PLANTRONICS INC. | 0.1% | $1.7M | $1.7B | FY 2022 |
| GLOBUS MEDICAL INC | 0.1% | $2.3M | $2.9B | FY 2025 |
| FACTSET RESEARCH SYSTEMS INC. | 0.1% | $1.8M | $2.3B | FY 2025 |
| MORNING STAR INC | 0.1% | $1.9M | $2.4B | FY 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 0.1% | $2.0M | $3.0B | FY 2025 |
| FLOWSERVE CORP | 0.1% | $3.0M | $4.7B | FY 2025 |
| COHERENT, INC. | 0.1% | $681.3k | $1.5B | FY 2021 |
| CADENCE DESIGN SYSTEMS INC | 0.1% | $2.6M | $5.3B | FY 2025 |
| CLOUDFLARE, INC. | 0.1% | $986.3k | $2.2B | FY 2025 |
| Sinclair, Inc. | 0.0% | $1.2M | $3.2B | FY 2025 |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | 0.0% | $2.0M | $5.0B | FY 2026 |
| REPUBLIC SERVICES, INC. | 0.0% | $6.2M | $16.6B | FY 2025 |
| MillerKnoll, Inc. | 0.0% | $1.6M | $3.8B | FY 2026 |
| ILLINOIS TOOL WORKS INC. | 0.0% | $4.7M | $16.0B | FY 2025 |
| DXP ENTERPRISES INC | 0.0% | $646.1k | $2.0B | FY 2025 |
| Delta Air Lines, Inc. | 0.0% | $19.0M | $63.4B | FY 2025 |
| METROPOLITAN LIFE INSURANCE CO | 0.0% | $14.8M | $43.3B | FY 2025 |
| CAL-MAINE FOODS, INC. | 0.0% | $940.0k | $2.9B | FY 2026 |
| Haemonetics Corporation | 0.0% | $372.6k | $1.3B | FY 2026 |
| MDU RESOURCES GROUP, INC. | 0.0% | $316.3k | $1.9B | FY 2025 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.0% | $7.6M | $48.2B | FY 2025 |
| OUTFRONT MEDIA INC. | 0.0% | $327.1k | $1.8B | FY 2025 |
| BARNES GROUP INC | 0.0% | $233.7k | $1.5B | FY 2023 |
| BENCHMARK ELECTRONICS, INC | 0.0% | $606.5k | $2.7B | FY 2025 |
| APTARGROUP, INC. | 0.0% | $650.0k | $3.8B | FY 2025 |
| S&P GLOBAL INC. | 0.0% | $3.6M | $15.3B | FY 2025 |
| FEDERAL SIGNAL CORPORATION | 0.0% | $341.2k | $2.2B | FY 2025 |
| AMERICAN ELECTRIC POWER COMPANY, INC. | 0.0% | $5.1M | $21.7B | FY 2025 |
| THE SHERWIN-WILLIAMS COMPANY | 0.0% | $3.4M | $23.6B | FY 2025 |
| SERVICENOW, INC. | 0.0% | $749.1k | $13.3B | FY 2025 |
| PENUMBRA, INC. | 0.0% | $200.0k | $1.4B | FY 2025 |
| CISCO SYSTEMS, INC. | 0.0% | $8.9M | $63.3B | FY 2026 |
| DARLING INGREDIENTS INC. | 0.0% | $352.0k | $6.1B | FY 2026 |
| BECTON, DICKINSON AND COMPANY | 0.0% | $1.4M | $21.8B | FY 2025 |
| LINCOLN ELECTRIC HOLDINGS INC | 0.0% | $315.9k | $4.2B | FY 2025 |
| INTERFACE, INC. | 0.0% | $146.8k | $1.4B | FY 2025 |
| TD SYNNEX CORPORATION | 0.0% | $6.6M | $62.5B | FY 2025 |
| TRIMBLE INC. | 0.0% | $505.9k | $3.6B | FY 2026 |
| ESSENTIAL UTILITIES, INC. | 0.0% | $495.8k | $5.1B | FY 2025 |
| CONTINENTAL RESOURCES, INC. | 0.0% | $380.2k | $7.0B | FY 2025 |
| SYNOPSYS INC | 0.0% | $983.9k | $7.1B | FY 2025 |
| FIDELITY NATIONAL INFORMATION SERVICES, INC. | 0.0% | $1.4M | $10.7B | FY 2025 |
| CONAGRA BRANDS, INC. | 0.0% | $864.4k | $11.3B | FY 2026 |
| ARROW ELECTRONICS, INC. | 0.0% | $1.3M | $30.9B | FY 2025 |
| WASTE MANAGEMENT INC | 0.0% | $-33.2k | $25.2B | FY 2025 |
| INSIGHT ENTERPRISES, INC. | 0.0% | $335.3k | $8.2B | FY 2025 |
| GREEN PLAINS INC. | 0.0% | $0 | $2.5B | FY 2024 |
| AMPHENOL CORPORATION | 0.0% | $36.0k | $23.1B | FY 2025 |
| HUNTINGTON INGALLS INDUSTRIES, INC. | 0.0% | $383.4k | $11.5B | FY 2023 |
| COHERENT CORP | 0.0% | $0 | $7.1B | FY 2026 |
| FLOWERS FOODS, INC | 0.0% | $0 | $4.8B | FY 2022 |
| NEUROCRINE BIOSCIENCES INC | 0.0% | $0 | $2.9B | FY 2025 |
| ABBOTT LABORATORIES | 0.0% | $255.9k | $44.3B | FY 2025 |
| RINGCENTRAL, INC. | 0.0% | $34.4k | $2.5B | FY 2025 |
| CARDINAL HEALTH, INC. | 0.0% | $4.5M | $254.2B | FY 2026 |
| THE GOODYEAR TIRE & RUBBER COMPANY | 0.0% | $0 | $18.3B | FY 2025 |
| PARSONS CORPORATION | 0.0% | $9.6k | $6.4B | FY 2025 |
| PATTERSON COMPANIES, INC. | 0.0% | $312.5k | $6.6B | FY 2024 |
| AVERY DENNISON CORPORATION | 0.0% | $15.5k | $8.9B | FY 2025 |
| MARTIN MARIETTA MATERIALS INC | 0.0% | $62.2k | $6.2B | FY 2025 |
| SAREPTA THERAPEUTICS, INC. | 0.0% | $0 | $1.9B | FY 2025 |
| Vista Outdoor Inc | 0.0% | $0 | $3.1B | FY 2023 |
| AMERICAN TOWER CORPORATION | 0.0% | $53.6k | $10.6B | FY 2025 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.0% | $0 | $3.7B | FY 2025 |
| TEXTRON INC. | 0.0% | $0 | $14.8B | FY 2026 |
| BORGWARNER INC. | 0.0% | $0 | $14.3B | FY 2025 |
| Leidos Holdings, Inc. | 0.0% | $-16.9k | $16.6B | FY 2025 |
| CASELLA WASTE SYSTEMS, INC. | 0.0% | $25.3k | $1.8B | FY 2025 |
| VULCAN MATERIALS COMPANY | 0.0% | $0 | $7.9B | FY 2025 |
| Dominion Energy, Inc. | 0.0% | $-212.8k | $16.5B | FY 2025 |
| NRG Energy Inc | 0.0% | $140.5k | $30.3B | FY 2025 |
| DENTSPLY SIRONA INC. | 0.0% | $88.5k | $3.7B | FY 2025 |
| UNITED PARCEL SERVICE INC | 0.0% | $940.6k | $88.7B | FY 2025 |
| INTERNATIONAL PAPER COMPANY | 0.0% | $0 | $23.6B | FY 2025 |
| CITRIX SYSTEMS, INC. | 0.0% | $31.5k | $3.2B | FY 2021 |
| Powell Industries, Inc. | 0.0% | $50.3k | $1.1B | FY 2025 |
| Salesforce, Inc. | 0.0% | $1.7k | $31.4B | FY 2023 |
| DXC TECHNOLOGY COMPANY | 0.0% | $0 | $12.6B | FY 2026 |
| EXELIXIS, INC. | 0.0% | $0 | $2.3B | FY 2026 |
| A. O. SMITH CORPORATION | 0.0% | $0 | $3.8B | FY 2025 |
| BIOMARIN PHARMACEUTICAL INC | 0.0% | $0 | $3.2B | FY 2025 |
| SOUTHWEST AIRLINES CO. | 0.0% | $703.2k | $28.1B | FY 2025 |
| EQUIFAX INC. | 0.0% | $186.9k | $6.1B | FY 2025 |
| PTC THERAPEUTICS, INC. | 0.0% | $0 | $1.7B | FY 2025 |
| Duolingo, Inc. | 0.0% | $6.8k | $1.0B | FY 2025 |
| PALO ALTO NETWORKS, INC | 0.0% | $0 | $11.5B | FY 2026 |
| MARSH & MCLENNAN COMPANIES, INC. | 0.0% | $23.7k | $27.0B | FY 2025 |
| Zoom Communications, Inc. | 0.0% | $-1.5k | $4.9B | FY 2026 |
| REVVITY, INC | 0.0% | $0 | $2.9B | FY 2025 |
| INCYTE CORPORATION | 0.0% | $0 | $5.1B | FY 2025 |
| NVIDIA CORP | 0.0% | $0 | $215.9B | FY 2026 |
| META PLATFORMS, INC | 0.0% | $7.4k | $201.0B | FY 2025 |
| CENCORA, INC. | 0.0% | $0 | $214.0B | FY 2021 |
| SCHOLASTIC CORPORATION | 0.0% | $12.5k | $1.7B | FY 2023 |
| CBRE GROUP, INC | 0.0% | $-161 | $35.2B | FY 2024 |
| ADVANCED DRAINAGE SYSTEMS, INC. | 0.0% | $0 | $3.1B | FY 2026 |
| WATERS CORPORATION | 0.0% | $-6.7k | $3.2B | FY 2025 |
| ARTHUR J. GALLAGHER & CO. | 0.0% | $582.0k | $13.9B | FY 2025 |
| UnitedHealth Group Incorporated | 0.0% | $307.9k | $324.2B | FY 2022 |
| SCANSOURCE INC | 0.0% | $0 | $3.2B | FY 2026 |
| ROBERT HALF INC. | 0.0% | $250.0k | $6.4B | FY 2023 |
| UBER TECHNOLOGIES, INC. | 0.0% | $127.5k | $52.0B | FY 2025 |
| TYLER TECHNOLOGIES, INC. | 0.0% | $10.1k | $2.3B | FY 2025 |
| LUMEN TECHNOLOGIES, INC. | 0.0% | $39.2k | $11.3B | FY 2025 |
| Cintas Corporation | 0.0% | $83.4k | $11.3B | FY 2026 |
| WESCO International, Inc. | 0.0% | $12.2k | $23.5B | FY 2025 |
| THE NEW YORK TIMES COMPANY | 0.0% | $-23.7k | $2.8B | FY 2025 |
| GILEAD SCIENCES, INC. | -0.0% | $-9.5M | $29.4B | FY 2025 |
| HENRY SCHEIN, INC. | -0.2% | $-29.5M | $13.2B | FY 2025 |
| VSE CORPORATION | -0.6% | $-6.5M | $1.1B | FY 2025 |
| REGENERON PHARMACEUTICALS, INC. | -2.3% | $-331.7M | $14.3B | FY 2025 |
| Novavax, Inc. | -6.3% | $-71.2M | $1.1B | FY 2025 |
Smaller companies (below $1B revenue; shares above 100% mean federal awards exceed reported revenue)
| Company | Share | Federal obligations | Revenue | Latest FY |
|---|---|---|---|---|
| Molekule Group, Inc. | 210.2% | $477.5k | $227.2k | FY 2022 |
| DARE BIOSCIENCE, INC. | 195.7% | $2.0M | $1.0M | FY 2025 |
| ENSYSCE BIOSCIENCES, INC. | 104.4% | $5.3M | $5.1M | FY 2025 |
| MARKER THERAPEUTICS, INC. | 99.9% | $3.5M | $3.5M | FY 2025 |
| Sintx Technologies, Inc. | 66.3% | $675.2k | $1.0M | FY 2025 |
| GRITSTONE BIO, INC. | 60.3% | $9.9M | $16.3M | FY 2023 |
| CARTESIAN THERAPEUTICS, INC. | 53.5% | $1.5M | $2.8M | FY 2025 |
| APPLIED ENERGETICS, INC | 43.3% | $200.0k | $461.7k | FY 2025 |
| TEL-INSTRUMENT ELECTRONICS CORP | 33.6% | $3.1M | $9.3M | FY 2025 |
| UNITED STATES ANTIMONY CORPORATION | 25.3% | $9.9M | $39.3M | FY 2025 |
| PERSONALIS, INC. | 19.9% | $13.8M | $69.6M | FY 2025 |
| RANK ONE COMPUTING CORPORATION | 19.3% | $3.3M | $17.0M | FY 2025 |
| QUANTUM COMPUTING INC. | 14.0% | $95.7k | $682.0k | FY 2025 |
| EBR SYSTEMS, INC | 11.7% | $189.9k | $1.6M | FY 2025 |
| TELOS CORPORATION | 10.5% | $17.3M | $164.8M | FY 2025 |
| Titan Environmental Solutions Inc. | 8.0% | $767.8k | $9.6M | FY 2024 |
| GSI TECHNOLOGY, INC. | 7.9% | $2.0M | $25.1M | FY 2026 |
| BNB PLUS CORP. | 6.8% | $145.1k | $2.1M | FY 2025 |
| INTERLINK ELECTRONICS, INC | 6.8% | $806.3k | $11.9M | FY 2025 |
| Opus Genetics, Inc. | 5.9% | $836.9k | $14.2M | FY 2025 |
| LOGICMARK, INC. | 5.5% | $633.8k | $11.4M | FY 2025 |
| AMERIGUARD SECURITY SERVICES, INC. | 4.1% | $963.7k | $23.5M | FY 2025 |
| OVERSEAS SHIPHOLDING GROUP INC | 3.9% | $17.5M | $451.9M | FY 2023 |
| QUANTUM SI INCORPORATED | 3.8% | $92.1k | $2.4M | FY 2025 |
| Taylor Devices, Inc. | 3.2% | $1.3M | $41.6M | FY 2026 |
| CLEARTRONIC, INC. | 2.9% | $118.0k | $4.1M | FY 2025 |
| Nikola Corporation | 2.8% | $1.4M | $49.7M | FY 2022 |
| PERMA FIX ENVIRONMENTAL SERVICES INC | 2.3% | $1.4M | $61.7M | FY 2025 |
| NEUROPACE INC | 2.1% | $2.1M | $100.0M | FY 2025 |
| HARVARD BIOSCIENCE, INC. | 1.8% | $1.6M | $86.5M | FY 2025 |
| APPIAN CORPORATION | 1.7% | $12.4M | $726.9M | FY 2025 |
| MERCURY SYSTEMS INC | 1.6% | $15.7M | $983.6M | FY 2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 1.3% | $2.0M | $160.0M | FY 2025 |
| Standard BioTools Inc. | 1.2% | $1.0M | $85.3M | FY 2025 |
| PCS EDVENTURES!, INC. | 1.2% | $89.6k | $7.4M | FY 2025 |
| KVH INDUSTRIES INC | 1.1% | $1.2M | $111.0M | FY 2025 |
| KIMBALL INTERNATIONAL INC | 0.9% | $6.3M | $665.9M | FY 2022 |
| SOLITRON DEVICES INC | 0.9% | $154.0k | $17.0M | FY 2026 |
| MERIDIAN BIOSCIENCE, INC. | 0.8% | $2.6M | $333.0M | FY 2022 |
| ARIS WATER SOLUTIONS, INC. | 0.7% | $3.2M | $435.4M | FY 2024 |
| MAXCYTE, INC. | 0.5% | $104.9k | $21.0M | FY 2025 |
| NEURAXIS, INC. | 0.5% | $18.0k | $3.6M | FY 2025 |
| Rapid Micro Biosystems, Inc. | 0.4% | $148.1k | $33.6M | FY 2025 |
| COURSERA, INC. | 0.4% | $3.3M | $757.5M | FY 2025 |
| AVID TECHNOLOGY, INC. | 0.4% | $1.5M | $417.4M | FY 2022 |
| SOUNDTHINKING, INC. | 0.4% | $361.0k | $104.1M | FY 2025 |
| BIODESIX, INC. | 0.3% | $300.2k | $88.5M | FY 2025 |
| MINERVA SURGICAL, INC. | 0.3% | $167.2k | $50.3M | FY 2022 |
| IRIDEX CORP | 0.3% | $173.8k | $52.7M | FY 2026 |
| ISIGN SOLUTIONS INC | 0.3% | $3.1k | $987.0k | FY 2022 |
| AKOYA BIOSCIENCES, INC | 0.3% | $226.4k | $81.7M | FY 2024 |
| Treace Medical Concepts, Inc. | 0.2% | $503.6k | $212.7M | FY 2025 |
| ACCELERATE DIAGNOSTICS, INC. | 0.2% | $24.8k | $11.7M | FY 2024 |
| EXPONENT INC | 0.2% | $1.2M | $582.0M | FY 2026 |
| SUNPOWER, INC | 0.2% | $604.7k | $300.0M | FY 2025 |
| MANDIANT, INC. | 0.2% | $809.8k | $483.5M | FY 2021 |
| Wireless Telecom Group, Inc. | 0.2% | $37.7k | $22.7M | FY 2021 |
| QUANTERIX CORPORATION | 0.1% | $210.3k | $138.9M | FY 2025 |
| ARTIVION, INC. | 0.1% | $681.4k | $441.3M | FY 2025 |
| STAAR SURGICAL CO | 0.1% | $331.3k | $239.4M | FY 2026 |
| AVANOS MEDICAL, INC. | 0.1% | $873.6k | $701.2M | FY 2025 |
| TAT TECHNOLOGIES LTD. | 0.1% | $193.0k | $178.0M | FY 2025 |
| XOMETRY, INC. | 0.1% | $619.1k | $686.6M | FY 2025 |
| MIRUM PHARMACEUTICALS, INC. | 0.1% | $458.5k | $521.3M | FY 2025 |
| 908 DEVICES INC. | 0.1% | $37.4k | $56.2M | FY 2025 |
| TRAVERE THERAPEUTICS, INC. | 0.1% | $334.9k | $490.7M | FY 2025 |
| VAPOTHERM, INC. | 0.1% | $43.8k | $68.7M | FY 2023 |
| PROTO LABS, INC. | 0.1% | $303.9k | $533.1M | FY 2025 |
| WOLFSPEED, INC. | 0.1% | $487.3k | $757.6M | FY 2025 |
| RICHARDSON ELECTRONICS, LTD. | 0.1% | $146.6k | $228.6M | FY 2026 |
| RETRACTABLE TECHNOLOGIES INC | 0.1% | $20.5k | $38.3M | FY 2025 |
| INVITAE CORPORATION | 0.1% | $233.8k | $516.3M | FY 2022 |
| TELA Bio, Inc. | 0.0% | $34.4k | $80.3M | FY 2025 |
| The Gorman-Rupp Company | 0.0% | $186.7k | $682.4M | FY 2025 |
| FULGENT GENETICS, INC. | 0.0% | $49.4k | $322.7M | FY 2025 |
| PSYCHEMEDICS CORPORATION | 0.0% | $3.7k | $22.1M | FY 2023 |
| CRA International, Inc. | 0.0% | $145.0k | $751.6M | FY 2026 |
| Neuronetics, Inc | 0.0% | $28.3k | $149.2M | FY 2025 |
| DAY ONE BIOPHARMACEUTICALS, INC. | 0.0% | $25.9k | $158.2M | FY 2025 |
| Doximity, Inc. | 0.0% | $130.5k | $644.9M | FY 2026 |
| ALEXANDERS INC | 0.0% | $17.2k | $213.2M | FY 2025 |
| DMC GLOBAL INC. | 0.0% | $59.6k | $719.2M | FY 2023 |
| SHUTTERSTOCK, INC. | 0.0% | $105.5k | $989.9M | FY 2025 |
| SIDUS SPACE, INC. | 0.0% | $100 | $1.8M | FY 2025 |
| UFP Technologies, Inc. | 0.0% | $3.6k | $602.8M | FY 2025 |
| AGIOS PHARMACEUTICALS, INC. | 0.0% | $0 | $54.0M | FY 2025 |
| URBAN ONE, INC. | 0.0% | $0 | $374.4M | FY 2025 |
| ELECTROMED, INC. | 0.0% | $0 | $73.8M | FY 2026 |
| Ocean Power Technologies, Inc. | 0.0% | $0 | $3.7M | FY 2026 |
| VALUE LINE INC | 0.0% | $0 | $33.4M | FY 2026 |
| BLINK CHARGING CO. | 0.0% | $0 | $103.5M | FY 2025 |
| PHATHOM PHARMACEUTICALS, INC. | 0.0% | $0 | $175.1M | FY 2025 |
| R C M TECHNOLOGIES, INC. | 0.0% | $0 | $319.4M | FY 2026 |
| CUMBERLAND PHARMACEUTICALS, INC. | 0.0% | $0 | $44.5M | FY 2025 |
| Y-MABS THERAPEUTICS, INC | 0.0% | $0 | $87.7M | FY 2024 |
| ARCUTIS BIOTHERAPEUTICS, INC. | 0.0% | $0 | $372.1M | FY 2025 |
| MANNKIND CORPORATION | 0.0% | $0 | $349.0M | FY 2025 |
| INVIVYD, INC. | 0.0% | $0 | $53.4M | FY 2025 |
| TRANSMONTAIGNE PARTNERS LLC | 0.0% | $0 | $646.0M | FY 2025 |
| MIMEDX GROUP, INC. | 0.0% | $7.9k | $418.6M | FY 2025 |
| TARSUS PHARMACEUTICALS, INC. | 0.0% | $0 | $451.4M | FY 2025 |
| INTERCEPT PHARMACEUTICALS INC | 0.0% | $0 | $285.7M | FY 2022 |
| SAFE PRO GROUP INC. | 0.0% | $0 | $606.7k | FY 2025 |
| LEXICON PHARMACEUTICALS, INC. | 0.0% | $0 | $49.8M | FY 2025 |
| TG THERAPEUTICS, INC. | 0.0% | $0 | $616.3M | FY 2025 |
| EVOFEM BIOSCIENCES, INC. | 0.0% | $0 | $20.2M | FY 2025 |
| Esperion Therapeutics, Inc. | 0.0% | $0 | $403.1M | FY 2025 |
| ARDELYX, INC. | 0.0% | $20.2k | $407.3M | FY 2025 |
| LIGHTPATH TECHNOLOGIES INC | 0.0% | $0 | $37.2M | FY 2025 |
| CATALYST PHARMACEUTICALS, INC. | 0.0% | $19.0k | $589.0M | FY 2025 |
| SPRINGWORKS THERAPEUTICS, INC. | 0.0% | $0 | $172.0M | FY 2024 |
| Aquestive Therapeutics, Inc. | 0.0% | $0 | $44.5M | FY 2025 |
| CleanCore Solutions, Inc. | 0.0% | $0 | $2.1M | FY 2025 |
| Eton Pharmaceuticals, Inc. | 0.0% | $0 | $80.0M | FY 2025 |
| PARK AEROSPACE CORP. | 0.0% | $0 | $73.3M | FY 2026 |
| ZIONS BANCORPORATION, NATIONAL ASSOCIATION | 0.0% | $0 | $529.0M | FY 2025 |
| DAILY JOURNAL CORPORATION | 0.0% | $0 | $87.7M | FY 2025 |
| UNITED GUARDIAN INC | 0.0% | $0 | $10.5M | FY 2025 |
| RHYTHM PHARMACEUTICALS, INC. | 0.0% | $0 | $189.8M | FY 2025 |
| INMUNE BIO INC. | 0.0% | $0 | $50.0k | FY 2025 |
| ALIMERA SCIENCES, INC. | 0.0% | $0 | $80.8M | FY 2023 |
| ADMA BIOLOGICS, INC. | 0.0% | $0 | $510.2M | FY 2025 |
| PUMA BIOTECHNOLOGY, INC. | 0.0% | $0 | $228.4M | FY 2025 |
| System1, Inc. | 0.0% | $0 | $266.1M | FY 2025 |
| CAREVIEW COMMUNICATIONS, INC. | 0.0% | $0 | $9.0M | FY 2025 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | -0.0% | $-32.6k | $277.0M | FY 2025 |
| INNODATA INC | -0.1% | $-150.0k | $251.7M | FY 2025 |
| 60 DEGREES PHARMACEUTICALS, INC. | -2.9% | $-29.0k | $1.0M | FY 2025 |
| BIOCRYST PHARMACEUTICALS, INC. | -3.3% | $-28.8M | $874.8M | FY 2025 |
| FUELCELL ENERGY, INC. | -4.2% | $-6.7M | $158.2M | FY 2025 |
Share = federal obligations (USAspending, consolidated across the corporate group) / revenue as filed with the SEC, most recent computable fiscal year per company. Precomputed weekly in the database - never by a model. '≥' marks floors (grant data not yet loaded).
- The two periods do not align exactly: revenue follows the company's fiscal year, obligations the US federal fiscal year (Oct-Sep).
- Years marked 'contracts only': grant/assistance awards are not yet loaded - the share is a floor, not the full figure.
- Fiscal years without a share: obligations base files not yet loaded; a missing value means missing load, not zero government business.
- Obligations are amounts obligated, not amounts paid out.
- The share consolidates all registrations of the corporate group via evidence-backed identity links (same_as facts).
Machine access — free, no API key
Every figure shown here about Which US companies depend most on US federal money? can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.
These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.